MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹2.25 Cr | ₹2.69 Cr | ₹2.48 Cr | - | - |
What is the latest Deferred Tax Assets / Liabilities ratio of MOREPEN LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹2.25 Cr |
Mar2023 | ₹2.69 Cr |
Mar2022 | ₹2.48 Cr |
Mar2021 | - |
Mar2020 | - |
How is Deferred Tax Assets / Liabilities of MOREPEN LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2.25 Cr | -16.23 | |
Mar2023 | ₹2.69 Cr | 8.18 | |
Mar2022 | ₹2.48 Cr | 0 | |
Mar2021 | - | 0 | |
Mar2020 | - | - |
Compare Deferred Tax Assets / Liabilities of peers of MOREPEN LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MOREPEN LABORATORIES | ₹3,696.3 Cr | 3.9% | -19.8% | 40.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,557.0 Cr | 2.3% | -0.8% | 32.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,994.0 Cr | 3.2% | 1.1% | 51.5% | Stock Analytics | |
CIPLA | ₹116,494.0 Cr | 0.3% | -2% | 10% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,297.0 Cr | -1.8% | 2.7% | 12.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,035.0 Cr | 2% | 1.5% | 38% | Stock Analytics |
MOREPEN LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MOREPEN LABORATORIES | 3.9% |
-19.8% |
40.5% |
SENSEX | -1% |
-5% |
5.6% |
You may also like the below Video Courses